DCH Auriga selected as the exclusive distributor of the Sinovac COVID-19 vaccine in Hong Kong
HONG KONG, Feb 18, 2021 - (ACN Newswire) - DCH Auriga, one of the largest healthcare distributors in Hong Kong, is pleased to announce it has been selected by the Hong Kong Department of Health to exclusively manage the storage and delivery of the Sinovac vaccine in Hong Kong.Under the agreement, DCH Auriga Hong Kong Ltd. will leverage its specialty cold chain expertise and unique healthcare-dedicated infrastructure for the safe and timely distribution of the Sinovac COVID-19 vaccine. Tim Collins, the CEO of DCH Auriga said, "We are honoured by the continued trust and support of the Hong Kong Department of Health and for the opportunity to leverage our capabilities to benefit our local community. With decades of experience managing pharmaceutical cold chain distribution, state-of-the-art facilities and robust quality assurance protocols, we are confident in our ability to safely and securely deliver the Sinovac vaccine in full accordance to the directives of the Government's vaccination program."About DCH AurigaDCH Auriga, a subsidiary of Dah Chong Hong Holdings Limited, is an Asia-based market management provider specialising in healthcare. Offering comprehensive commercial and lo...
